Upgrade to SI Premium - Free Trial

Ackman's Pershing Square Moves Stake in Valeant Pharma (VRX) to 9.9%

November 23, 2015 5:17 PM
In an amended 13D filing on Valeant Pharma (NYSE: VRX), Bill Ackman's hedge fund Pershing Square Capital disclosed a 9.9 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

13Ds Hedge Funds

Next Articles